Clinical features of acute viral hepatitis B in Korea

a multi-center study.

Hye Jin Choi, Soon Young Ko, Won Hyeok Choe, Yeon Seok Seo, Ji Hoon Kim, Kwan Soo Byun, Young Seok Kim, Seungup Kim, Soonkoo Baik, Jae Youn Cheong, Tae Yeob Kim, Oh Sang Kwon, Jeong Han Kim, Chang Hong Lee, So Young Kwon

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

The incidence of Hepatitis B has significantly declined since the introduction of an HBV vaccination program. The aim of this study was to investigate recent clinical features of acute viral hepatitis B (AVH-B) in Korea. A total of 2241 patients with acute viral hepatitis were enrolled and their data were collected from nine medical-centers between January 2006 and December 2009. One hundred nineteen (5.3%) of the 2241 were diagnosed as AVH-B. Among 78 patients with AVH-B whose data were analyzed, 50 were male, and the mean age was 38.6 years. In an initial test, mean AST, ALT and total-bilirubin levels were 1296.2 IU/L, 2109.6 IU/L and 9.3 mg/dl, respectively. Positivity frequencies for HBeAg and anti-HBe were 55.1% and 67.9%, respectively, and the mean HBV DNA level was 5.2 log10 copies/ml. The mean length of hospitalization was 11.6 days. During follow-up, AST, ALT and total bilirubin levels were normalized or near-normalized in all patients without serious complications. Sixty-three of 66 (95.4%) patients showed HBsAg loss and 37 (56.1%) patients showed HBsAg seroconversion. Only 3 patients (4.5%) showed persistent hepatitis B viremia. There was no case of death or liver transplantation. Nine patients (11.3%) had received anti-viral agents and their clinical outcomes were not significantly different from those of patients treated without antiviral agents. The prevalence of AVH-B among acute hepatitis patients is relatively low in Korea. AVH-B infection can be cured without complications in almost all patients, regardless of antiviral treatment.

Original languageEnglish
Pages (from-to)307-312
Number of pages6
JournalThe Korean journal of hepatology
Volume17
Issue number4
DOIs
Publication statusPublished - 2011 Dec 1

Fingerprint

Korea
Hepatitis B
Hepatitis B Surface Antigens
Bilirubin
Hepatitis
Antiviral Agents
Hepatitis B e Antigens
Viremia
Liver Transplantation
Vaccination
Hospitalization
DNA
Incidence

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Cite this

Choi, H. J., Ko, S. Y., Choe, W. H., Seo, Y. S., Kim, J. H., Byun, K. S., ... Kwon, S. Y. (2011). Clinical features of acute viral hepatitis B in Korea: a multi-center study. The Korean journal of hepatology, 17(4), 307-312. https://doi.org/10.3350/kjhep.2011.17.4.307
Choi, Hye Jin ; Ko, Soon Young ; Choe, Won Hyeok ; Seo, Yeon Seok ; Kim, Ji Hoon ; Byun, Kwan Soo ; Kim, Young Seok ; Kim, Seungup ; Baik, Soonkoo ; Cheong, Jae Youn ; Kim, Tae Yeob ; Kwon, Oh Sang ; Kim, Jeong Han ; Lee, Chang Hong ; Kwon, So Young. / Clinical features of acute viral hepatitis B in Korea : a multi-center study. In: The Korean journal of hepatology. 2011 ; Vol. 17, No. 4. pp. 307-312.
@article{cb503b88a2d44e1e924c2b1c6a32238e,
title = "Clinical features of acute viral hepatitis B in Korea: a multi-center study.",
abstract = "The incidence of Hepatitis B has significantly declined since the introduction of an HBV vaccination program. The aim of this study was to investigate recent clinical features of acute viral hepatitis B (AVH-B) in Korea. A total of 2241 patients with acute viral hepatitis were enrolled and their data were collected from nine medical-centers between January 2006 and December 2009. One hundred nineteen (5.3{\%}) of the 2241 were diagnosed as AVH-B. Among 78 patients with AVH-B whose data were analyzed, 50 were male, and the mean age was 38.6 years. In an initial test, mean AST, ALT and total-bilirubin levels were 1296.2 IU/L, 2109.6 IU/L and 9.3 mg/dl, respectively. Positivity frequencies for HBeAg and anti-HBe were 55.1{\%} and 67.9{\%}, respectively, and the mean HBV DNA level was 5.2 log10 copies/ml. The mean length of hospitalization was 11.6 days. During follow-up, AST, ALT and total bilirubin levels were normalized or near-normalized in all patients without serious complications. Sixty-three of 66 (95.4{\%}) patients showed HBsAg loss and 37 (56.1{\%}) patients showed HBsAg seroconversion. Only 3 patients (4.5{\%}) showed persistent hepatitis B viremia. There was no case of death or liver transplantation. Nine patients (11.3{\%}) had received anti-viral agents and their clinical outcomes were not significantly different from those of patients treated without antiviral agents. The prevalence of AVH-B among acute hepatitis patients is relatively low in Korea. AVH-B infection can be cured without complications in almost all patients, regardless of antiviral treatment.",
author = "Choi, {Hye Jin} and Ko, {Soon Young} and Choe, {Won Hyeok} and Seo, {Yeon Seok} and Kim, {Ji Hoon} and Byun, {Kwan Soo} and Kim, {Young Seok} and Seungup Kim and Soonkoo Baik and Cheong, {Jae Youn} and Kim, {Tae Yeob} and Kwon, {Oh Sang} and Kim, {Jeong Han} and Lee, {Chang Hong} and Kwon, {So Young}",
year = "2011",
month = "12",
day = "1",
doi = "10.3350/kjhep.2011.17.4.307",
language = "English",
volume = "17",
pages = "307--312",
journal = "Clinical and molecular hepatology",
issn = "2287-2728",
publisher = "Korean Association for the Study of the Liver",
number = "4",

}

Choi, HJ, Ko, SY, Choe, WH, Seo, YS, Kim, JH, Byun, KS, Kim, YS, Kim, S, Baik, S, Cheong, JY, Kim, TY, Kwon, OS, Kim, JH, Lee, CH & Kwon, SY 2011, 'Clinical features of acute viral hepatitis B in Korea: a multi-center study.', The Korean journal of hepatology, vol. 17, no. 4, pp. 307-312. https://doi.org/10.3350/kjhep.2011.17.4.307

Clinical features of acute viral hepatitis B in Korea : a multi-center study. / Choi, Hye Jin; Ko, Soon Young; Choe, Won Hyeok; Seo, Yeon Seok; Kim, Ji Hoon; Byun, Kwan Soo; Kim, Young Seok; Kim, Seungup; Baik, Soonkoo; Cheong, Jae Youn; Kim, Tae Yeob; Kwon, Oh Sang; Kim, Jeong Han; Lee, Chang Hong; Kwon, So Young.

In: The Korean journal of hepatology, Vol. 17, No. 4, 01.12.2011, p. 307-312.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Clinical features of acute viral hepatitis B in Korea

T2 - a multi-center study.

AU - Choi, Hye Jin

AU - Ko, Soon Young

AU - Choe, Won Hyeok

AU - Seo, Yeon Seok

AU - Kim, Ji Hoon

AU - Byun, Kwan Soo

AU - Kim, Young Seok

AU - Kim, Seungup

AU - Baik, Soonkoo

AU - Cheong, Jae Youn

AU - Kim, Tae Yeob

AU - Kwon, Oh Sang

AU - Kim, Jeong Han

AU - Lee, Chang Hong

AU - Kwon, So Young

PY - 2011/12/1

Y1 - 2011/12/1

N2 - The incidence of Hepatitis B has significantly declined since the introduction of an HBV vaccination program. The aim of this study was to investigate recent clinical features of acute viral hepatitis B (AVH-B) in Korea. A total of 2241 patients with acute viral hepatitis were enrolled and their data were collected from nine medical-centers between January 2006 and December 2009. One hundred nineteen (5.3%) of the 2241 were diagnosed as AVH-B. Among 78 patients with AVH-B whose data were analyzed, 50 were male, and the mean age was 38.6 years. In an initial test, mean AST, ALT and total-bilirubin levels were 1296.2 IU/L, 2109.6 IU/L and 9.3 mg/dl, respectively. Positivity frequencies for HBeAg and anti-HBe were 55.1% and 67.9%, respectively, and the mean HBV DNA level was 5.2 log10 copies/ml. The mean length of hospitalization was 11.6 days. During follow-up, AST, ALT and total bilirubin levels were normalized or near-normalized in all patients without serious complications. Sixty-three of 66 (95.4%) patients showed HBsAg loss and 37 (56.1%) patients showed HBsAg seroconversion. Only 3 patients (4.5%) showed persistent hepatitis B viremia. There was no case of death or liver transplantation. Nine patients (11.3%) had received anti-viral agents and their clinical outcomes were not significantly different from those of patients treated without antiviral agents. The prevalence of AVH-B among acute hepatitis patients is relatively low in Korea. AVH-B infection can be cured without complications in almost all patients, regardless of antiviral treatment.

AB - The incidence of Hepatitis B has significantly declined since the introduction of an HBV vaccination program. The aim of this study was to investigate recent clinical features of acute viral hepatitis B (AVH-B) in Korea. A total of 2241 patients with acute viral hepatitis were enrolled and their data were collected from nine medical-centers between January 2006 and December 2009. One hundred nineteen (5.3%) of the 2241 were diagnosed as AVH-B. Among 78 patients with AVH-B whose data were analyzed, 50 were male, and the mean age was 38.6 years. In an initial test, mean AST, ALT and total-bilirubin levels were 1296.2 IU/L, 2109.6 IU/L and 9.3 mg/dl, respectively. Positivity frequencies for HBeAg and anti-HBe were 55.1% and 67.9%, respectively, and the mean HBV DNA level was 5.2 log10 copies/ml. The mean length of hospitalization was 11.6 days. During follow-up, AST, ALT and total bilirubin levels were normalized or near-normalized in all patients without serious complications. Sixty-three of 66 (95.4%) patients showed HBsAg loss and 37 (56.1%) patients showed HBsAg seroconversion. Only 3 patients (4.5%) showed persistent hepatitis B viremia. There was no case of death or liver transplantation. Nine patients (11.3%) had received anti-viral agents and their clinical outcomes were not significantly different from those of patients treated without antiviral agents. The prevalence of AVH-B among acute hepatitis patients is relatively low in Korea. AVH-B infection can be cured without complications in almost all patients, regardless of antiviral treatment.

UR - http://www.scopus.com/inward/record.url?scp=84861315692&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84861315692&partnerID=8YFLogxK

U2 - 10.3350/kjhep.2011.17.4.307

DO - 10.3350/kjhep.2011.17.4.307

M3 - Article

VL - 17

SP - 307

EP - 312

JO - Clinical and molecular hepatology

JF - Clinical and molecular hepatology

SN - 2287-2728

IS - 4

ER -